IMURAN

This brand name is authorized in United States. It is also authorized in Australia, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Turkey, UK.

Active ingredients

The drug IMURAN contains one active pharmaceutical ingredient (API):

1	Azathioprine UNII MRK240IY2L - AZATHIOPRINE
	Azathioprine is a pro-drug of 6-mercaptopurine (6-MP). 6-MP is inactive but acts as a purine antagonist and requires cellular uptake and intracellular anabolism to thioguanine nucleotides (TGNs) for immunosuppression. The TGNs and other metabolites (e.g. 6-methyl-mecaptopurine ribonucleotides) inhibit de novo purine synthesis and purine nucleotide interconversions.
	Read more about Azathioprine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
IMURAN Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AX01	Azathioprine	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AX Other immunosuppressants
Discover more medicines within L04AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2687K, 2688L
BR	Câmara de Regulação do Mercado de Medicamentos	505612040035714, 505613110039803
CA	Health Products and Food Branch	00004596, 02244895
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	29909-07-11
EE	Ravimiamet	1004500, 1678158, 1865099
GB	Medicines & Healthcare Products Regulatory Agency	20186, 20202, 27698, 381404
HK	Department of Health Drug Office	03804, 30975
HR	Agencija za lijekove i medicinske proizvode	HR-H-628872163
IE	Health Products Regulatory Authority	28762, 28847, 28894, 84612, 84625, 84638, 84662
IL	מִשְׂרַד הַבְּרִיאוּת	1107, 2457
JP	医薬品医療機器総合機構	3999005F1059
LT	Valstybinė vaistų kontrolės tarnyba	1000951, 1085691, 1085796
MT	Medicines Authority	AA565/76001
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	69062
NL	Z-Index G-Standaard, PRK	5681
NZ	Medicines and Medical Devices Safety Authority	16562, 337, 338
PL	Rejestru Produktów Leczniczych	100030481, 100030498
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W60846001
SG	Health Sciences Authority	02082P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699874080090, 8699874080106
US	FDA, National Drug Code	54766-590
ZA	Health Products Regulatory Authority	D/26/98